These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1519208)

  • 1. Gemfibrozil reduces plasma prothrombin fragment F1 + 2 concentration, a marker of coagulability, in patients with coronary heart disease.
    Wilkes HC; Meade TW; Barzegar S; Foley AJ; Hughes LO; Bauer KA; Rosenberg RD; Miller GJ
    Thromb Haemost; 1992 May; 67(5):503-6. PubMed ID: 1519208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
    Bröijersén A; Hamsten A; Silveira A; Fatah K; Goodall AH; Eriksson M; Angelin B; Hjemdahl P
    Thromb Haemost; 1996 Aug; 76(2):171-6. PubMed ID: 8865525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
    Athyros VG; Papageorgiou AA; Avramidis MJ; Kontopoulos AG
    Coron Artery Dis; 1995 Mar; 6(3):251-6. PubMed ID: 7788039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
    Musiał J; Pajak A; Undas A; Kawalec E; Topór-Madry R; Pazucha T; Grzywacz M; Szczeklik A
    Thromb Haemost; 1997 Apr; 77(4):697-700. PubMed ID: 9134645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC
    Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men.
    Miller GJ; Bauer KA; Barzegar S; Foley AJ; Mitchell JP; Cooper JA; Rosenberg RD
    Thromb Haemost; 1995 Jan; 73(1):82-6. PubMed ID: 7740501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.
    Miller GJ; Bauer KA; Barzegar S; Cooper JA; Rosenberg RD
    Thromb Haemost; 1996 May; 75(5):767-71. PubMed ID: 8725721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men.
    Sanders TA; Oakley FR; Crook D; Cooper JA; Miller GJ
    Br J Nutr; 2003 Jun; 89(6):767-76. PubMed ID: 12828793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients.
    Kockx M; de Maat MP; Knipscheer HC; Kastelein JJ; Kluft C; Princen HM; Kooistra T
    Thromb Haemost; 1997 Oct; 78(4):1167-72. PubMed ID: 9364979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB; Donega P; Passaro A; Zanca R; Cattin L; Fonda M; Pauciullo P; Marotta G; Fellin R; Gasparrini S; Piliego T
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment.
    Ikonomidis I; Lekakis J; Vamvakou G; Andreotti F; Nihoyannopoulos P
    Am Heart J; 2005 May; 149(5):832-9. PubMed ID: 15894964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency.
    Ingerslev J; Holm M; Christiansen K; Knudsen L; Négrier C
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S129-34. PubMed ID: 9819044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
    Assmann G; Cullen P; Heinrich J; Schulte H
    Isr J Med Sci; 1996 Jun; 32(6):364-70. PubMed ID: 8682642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilic variables do not increase the generation or procoagulant activity of thrombin during cardiopulmonary bypass.
    Raivio P; Petäjä J; Kuitunen A; Lassila R
    Ann Thorac Surg; 2008 Feb; 85(2):536-42. PubMed ID: 18222259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterol levels.
    Musiał J; Undas A; Undas R; Brozek J; Szczeklik A
    Thromb Haemost; 2001 Feb; 85(2):221-5. PubMed ID: 11246536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
    Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
    Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin fragment F1 + 2: correlations with cardiovascular risk factors.
    Rugman FP; Jenkins JA; Duguid JK; Maggs PB; Hay CR
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):335-40. PubMed ID: 8075305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
    Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.